Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan;79(1):31-44.
doi: 10.1007/s12020-022-03208-3. Epub 2022 Oct 26.

Vitamin D in the older population: a consensus statement

Affiliations
Review

Vitamin D in the older population: a consensus statement

Andrea Giustina et al. Endocrine. 2023 Jan.

Abstract

Background: This paper reports results from the 5th International Conference "Controversies in Vitamin D" that was held in Stresa, Italy, 15-18 September 2021. The conference is part of this series that started in 2017 and has been conducted annually since. The objective of these conferences is to identify timely and controversial topics related to Vitamin D. Dissemination of the results of the conference through publications in peer-reviewed journals is an important means by which the most up to date information can be shared with physicians, investigators, and other health care professionals. Vitamin D and aging, the subject of this paper was featured at the conference.

Methods: Participants were selected to review available literature on assigned topics related to vitamin D and aging and to present their findings with illustrative material, the intent of which was to stimulate discussion and to arrive at a consensus. The presentations were directed towards the following areas: impact of aging on vitamin D production and levels; skeletal effects of vitamin D deficiency in the older population; falls and vitamin D in the aging; potential extra skeletal effects of vitamin D; and strategies to prevent vitamin D deficiency. A final topic was related to how vitamin D might influence the efficacy of vaccines for Covid-19.

Results: Hypovitaminosis D can lead to several skeletal and extra-skeletal outcomes. Older adults are at risk for vitamin D deficiency as both production and metabolism of vitamin D change with aging due to factors, such as reduced sun exposure and reduced production capacity of the skin. Skeletal consequences of these age-related changes can include reduced bone mineral density, osteomalacia and fractures. Potential extra-skeletal effects can include added risks for falls, reduced muscle strength, diabetes, cancer, and cardiovascular disease. Strategies to avoid these vitamin D deficiency-related negative outcomes include sun exposure, food fortification, and supplementation. While aging does not diminish sufficient reserve capacity for cutaneous vitamin D production, concerns about skin cancers and practical matters for the institutionalized elderly limit this option. Supplementation with vitamin D is the best option either pharmacologically or through food fortification. Regardless of treatment strategies, interventions to restore sufficient vitamin D status will show positive results only in those who are truly deficient. Thus, treatment goals should focus on avoiding 25(OH)D serum levels <30 nmol/l, with a goal to reach levels >50 nmol/l.

Conclusions: The results of this conference has led to consensus on several issues. Vitamin D supplementation should be combined with calcium to reduce fractures in the older population. The goal for adequate Vitamin D status should be to reach a serum level of 25(OH)D >50 nmol/l. It appears that daily low-dose vitamin D regimens reduce the risk of falling, especially in the elderly, compared with infrequent, large bolus doses that may increase it. The role of Vitamin D supplementation on muscle strength remains to be clarified. On the other hand, supplementation decreases the risk of progression to T2D from prediabetes among those who are Vitamin Ddeficient. Of three possible strategies to establish vitamin D sufficiency - sunshine exposure, food fortification, and supplementation - the latter seems to be the most effective and practical in the aging population.

Keywords: Aging; Older people; Vitamin D; Vitamin D deficiency; Vitamin D supplementation.

PubMed Disclaimer

Conflict of interest statement

A.G. is consultant for Abiogen and Takeda and received research grant to Institution from Takeda, R.B. received lecture fees from Abiogen (Italy), FAES Farma (Spain) and Ceres (Belgium) outside of the submitted work. The other authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Vitamin D3 production age continuum modeling. The simple linear regression model with decade as the independent variable and log D3 production demonstrated the 13% decrease in D3 production per decade of life. D3 production at age 70 years is approximately half that produced at age 20 years. The graph also demonstrates that D3 production occurs even in the later decades of life. Source: Chalcraft et al. 2020 [10]. Reproduced from MDPI under an open access Creative Common CC BY license
Fig. 2
Fig. 2
Skeletal effects of vitamin D deficiency in the elderly and role of vitamin D in preventing them
Fig. 3
Fig. 3
Extra skeletal effects of vitamin D deficiency in the elderly and possible role of vitamin D in preventing them. Continuous lines indicate a known effect. Dashed lines indicate a possible effect
Fig. 4
Fig. 4
Strategies to avoid vitamin D deficiency in the elderly and related limitations

References

    1. Giustina A, Adler RA, Binkley N, Bouillon R, Ebeling PR, Lazaretti-Castro M, Marcocci C, Rizzoli R, Sempos CT, Bilezikian JP. Controversies in Vitamin D: summary statement from an international conference. J. Clin. Endocrinol. Metab. 2019;104:234–240. doi: 10.1210/jc.2018-01414. - DOI - PubMed
    1. Sempos CT, Heijboer AC, Bikle DD, Bollerslev J, Bouillon R, Brannon PM, DeLuca HF, Jones G, Munns CF, Bilezikian JP, Giustina A, Binkley N. Vitamin D assays and the definition of hypovitaminosis D: Results from the first international conference on controversies in vitamin D. Br. J. Clin. Pharmacol. 2018;84:2194–2207. doi: 10.1111/bcp.13652. - DOI - PMC - PubMed
    1. Ebeling PR, Adler RA, Jones G, Liberman UA, Mazziotti G, Minisola S, Munns CF, Napoli N, Pittas AG, Giustina A, Bilezikian JP, Rizzoli R. Management of endocrine disease: Therapeutics of vitamin D. Eur. J. Endocrinol. 2018;179:R239–R259. doi: 10.1530/EJE-18-0151. - DOI - PubMed
    1. Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, Lips P, Munns CF, Lazaretti-Castro M, Giustina A, Bilezikian J. Skeletal and extraskeletal actions of vitamin D: Current evidence and outstanding questions. Endocr. Rev. 2019;40:1109–1151. doi: 10.1210/er.2018-00126. - DOI - PMC - PubMed
    1. Giustina A, Adler RA, Binkley N, Bollerslev J, Bouillon R, Dawson-Hughes B, Ebeling PR, Feldman D, Formenti AM, Lazaretti-Castro M, Marcocci C, Rizzoli R, Sempos CT, Bilezikian JP. Consensus statement from 2nd International Conference on Controversies in Vitamin D. Rev. Endocr. Metab. Disord. 2020;21:89–116. doi: 10.1007/s11154-019-09532-w.. - DOI - PMC - PubMed

Publication types